LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | R406 | 0.04 | uM | LJP6 | 72 | hr | 513 | 9273 | 10401 | 0.8915 | 0.8859 |
MCF 10A | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 513 | 5147 | 10401 | 0.4949 | 0.4687 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 7067 | 10401 | 0.6795 | 0.6628 |
MCF 10A | Geldanamycin | 0.04 | uM | LJP5 | 72 | hr | 513 | 607 | 10401 | 0.0584 | 0.0095 |
MCF 10A | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 513 | 641 | 10401 | 0.0616 | 0.0129 |
MCF 10A | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10000 | 10401 | 0.9615 | 0.9595 |
MCF 10A | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 513 | 8625 | 10401 | 0.8293 | 0.8204 |
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 513 | 3073 | 10401 | 0.2955 | 0.2589 |
MCF 10A | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 513 | 714 | 10401 | 0.0687 | 0.0203 |
MCF 10A | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 513 | 9415 | 10401 | 0.9052 | 0.9003 |
MCF 10A | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 513 | 9055 | 10401 | 0.8706 | 0.8639 |
MCF 10A | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 513 | 9757 | 10401 | 0.9381 | 0.9349 |
MCF 10A | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 513 | 7496 | 10401 | 0.7207 | 0.7062 |
MCF 10A | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 10714 | 10401 | 1.0301 | 1.0316 |
MCF 10A | JNK-9L | 0.04 | uM | LJP6 | 72 | hr | 513 | 9018 | 10401 | 0.8671 | 0.8602 |
MCF 10A | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 513 | 9324 | 10401 | 0.8965 | 0.8911 |
MCF 10A | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 9294 | 10401 | 0.8936 | 0.8881 |
MCF 10A | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10621 | 10401 | 1.0212 | 1.0223 |
MCF 10A | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 513 | 11575 | 10401 | 1.1129 | 1.1188 |
MCF 10A | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 8348 | 10401 | 0.8026 | 0.7924 |
MCF 10A | Mitoxantrone | 0.04 | uM | LJP5 | 72 | hr | 513 | 1036 | 10401 | 0.0996 | 0.0529 |
MCF 10A | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 513 | 907 | 10401 | 0.0873 | 0.0399 |
MCF 10A | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 513 | 10448 | 10401 | 1.0045 | 1.0048 |
MCF 10A | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 1007 | 10401 | 0.0968 | 0.0499 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 10927 | 10401 | 1.0506 | 1.0533 |